Jul 18, 2024
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Cell and Gene Therapy Supply Chain/Logistics Market Size, Share & Trends Analysis Report By Application area (Donor eligibility assessment, Sample collection, Manufacturing, Logistics, Patient verification, and treatment follow-up), By Type of software solution (Cell orchestration platform, Enterprise manufacturing system, Inventory management system, Laboratory information management system, Logistics management system, Patient management system, Quality management system, Tracking and tracing system ), By Mode of Deployment (Cloud-Based, On-premises ), By End-user (Biobank, Cell therapy lab, Hospital, Research institute, Commercial organization)- Market Outlook And Industry Analysis 2031"
The Global Cell and Gene Therapy Supply Chain/Logistics Market is valued at US$ 1.35 Bn in 2023, and it is expected to reach US$ 3.17 Bn by 2031, with a CAGR of 11.41% during the forecast period of 2024-2031.
Request Complete FREE Sample Report Click Here: https://www.insightaceanalytic.com/request-sample/1694
The cell and gene therapy supply chain/logistics is a system designed to effectively deliver these life-saving treatments to patients. It involves several steps, with special considerations to ensure the fragile therapies are kept safe and viable throughout the journey. Rare diseases are treated with gene and cell treatments. Clinical trials for rare diseases will inevitably take place across many states or perhaps continents. This creates a difficulty that necessitates a robust and interconnected supply chain network, with supply chain participants working together to ensure the safe handling and transportation of temperature-sensitive cargo. The development of cell and gene therapy requires cooperation with logistics suppliers that have many logistical hubs in strategic locations in order to meet service expectations and lower cold chain risk.
Training for cell and gene therapy logistics should encompass shipping, storage, preparation, and administration of the therapies. It should also address the patient journey, coordination of treatment, cohort management, manufacturing slots, and involvement of surgical or interventional radiology. Supply chain vendors in cell and gene therapy, such as couriers, depot networks, tracking platforms, and patient concierges, need to be integrated into the logistics oversight.
Drivers-
Rising adoption of personalized therapies tailored to individual patient needs, particularly for rare and complex diseases. Growth in patient-centric approaches requiring sophisticated logistics solutions. Innovations in gene editing technologies such as CRISPR, enhance the development and delivery of cell and gene therapies. Accelerated approvals and supportive regulatory frameworks from agencies like the FDA and EMA, encourage the development and commercialization of cell and gene therapies. Increased focus on compliance and quality assurance driving the need for specialized logistics. Increased patient awareness and advocacy for access to advanced therapies driving demand and logistical needs.
Challenges:
Ensuring consistent temperature control (cold chain logistics) to maintain the viability and efficacy of therapies during transport and storage. Preventing contamination and preserving the genetic stability of the therapies throughout the supply chain.
Regional Trends:
The North America dominates the market. Leading in the adoption of advanced technologies such as AI, IoT, and blockchain for supply chain optimization and tracking. Significant investments in R&D and infrastructure for cell and gene therapy manufacturing and logistics. Strong regulatory frameworks and support from agencies like the FDA are driving innovation and adoption of cell and gene therapies. The Asia Pacific is rapidly expanding the market for cell and gene therapies, particularly in countries like China, Japan, and South Korea. Increasing government support and investment in biotechnology and regenerative medicine.
Application Area
Type of Software Solution
End-Use
Type of Deployment
By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-